The FDA-approved cyborg implant that lets the blind see again

While bulky and clumsy now, the Argus II vision system promises a very bright future

A new advanced vision system may mean Fido can go back to cuddling.
(Image credit: Thinkstock)

The Food and Drug Administration has approved a system combining a special pair of glasses with an artificial retina that helps people impaired with a certain kind of blindness see again. While their vision will still be far from normal, those afflicted with severe retinitis pigmentosa — a disease that affects 100,000 people nationwide — will be able to "detect crosswalks on the street, burners on a stove, the presence of people or cars, and sometimes even oversized numbers or letters," according to The New York Times. In other words, they'll be able to live something a little closer to a normal, independent life.

The advanced vision system, called Argus II, requires a sheet of electrodes to be surgically implanted inside a patient's eye, specifically, the back of the eyeball where the damaged retina is located. Afterward, patients are given a special pair of eyeglasses outfitted with a camera and a portable video processor. Working together, "these elements together allow visual signals to bypass the damaged portion of the retina and to be transmitted to the brain," says The Times.

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up
Chris Gayomali is the science and technology editor for TheWeek.com. Previously, he was a tech reporter at TIME. His work has also appeared in Men's Journal, Esquire, and The Atlantic, among other places. Follow him on Twitter and Facebook.